Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL

Author:

Vardi Anna1,Dagklis Antonis2,Scarfò Lydia2,Jelinek Diane3,Newton Darren4,Bennett Fiona4,Almeida Julia5,Rodriguez-Caballero Arancha5,Allgood Sallie6,Lanasa Mark6,Cortelezzi Agostino78,Orlandi Ester89,Veronese Silvio10,Montillo Marco810,Rawstron Andy4,Shanafelt Tait3,Orfao Alberto5,Stamatopoulos Kostas111,Ghia Paolo28

Affiliation:

1. Hematology Department and Hematopoietic Cell Transplantation Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;

2. Division of Molecular Oncology and Department of Onco-Hematology, Universita Vita-Salute San Raffaele and Istituto Scientifico San Raffaele, Milan, Italy;

3. Department of Immunology, Mayo Clinic, Rochester, MN;

4. Haematological Malignancy Diagnostic Service, St. James’s Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom;

5. Centro de Investigación del Cáncer and Department of Medicine, University of Salamanca, Salamanca, Spain;

6. Department of Medicine, Duke University Medical Center, Durham, NC;

7. Department of Medical Sciences, Hematology 1 Centro Trapianti di Midollo Osseo University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy;

8. Rete Ematologica Lombarda, Milan, Italy;

9. Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy;

10. Niguarda Ca’ Granda Hospital, Milan, Italy; and

11. Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece

Abstract

Key Points Low-count and high-count monoclonal B-cell lymphocytosis (MBL) have distinct immunogenetic signatures, with only the latter resembling CLL. Rather than a true premalignant condition, low-count MBL may merely reflect immune senescence or result from persistent antigen stimulation.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3